China Anti-obesity Drugs Market The anti-obesity drugs market in China, which was estimated to be USD 1.93 billion in 2025, is growing due to rapid domestic production of lower-cost GLP-1 biosimilars, increasing obesity-linked diabetes burden among urban populations, and strong government focus on chronic metabolic disease management
After supplementation with l-carnitine, especially in group D (high-dose), the hypoxic condition was improved to some extent
Always consult with a qualified healthcare provider before using any research compounds
Peppermint tea may help with bloating and digestive discomfort
The goals of therapy are to control inflammation, correct nutritional deficiencies, and relieve symptoms such as abdominal pain, diarrhea, and rectal bleeding